O. Camara

发表

Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.

T. Kroll, I. Runnebaum, K. Pachmann, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring

U. Schneider, K. Pachmann, O. Camara, 2005, Breast Cancer Research.

Inflammatory breast carcinoma in magnetic resonance imaging: a comparison with locally advanced breast cancer.

Joachim Böttcher, Mieczyslaw Gajda, Oumar Camara, 2008, Academic radiology.

Can color-coded parametric maps improve dynamic enhancement pattern analysis in MR mammography?

W. Kaiser, M. Dietzel, P. Baltzer, 2010, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

Application of artificial neural networks for the prediction of lymph node metastases to the ipsilateral axilla – initial experience in 194 patients using magnetic resonance mammography

W. Kaiser, M. Dietzel, P. Baltzer, 2010, Acta radiologica.

Enhancement profiles of malignant lesion subgroups in MR-mammography: A computer assisted evaluation considering pharmacokinetic parameters

W. Kaiser, M. Dietzel, P. Baltzer, 2010 .

Application of breast MRI for prediction of lymph node metastases – systematic approach using 17 individual descriptors and a dedicated decision tree

Matthias Dietzel, Tibor Vag, Mieczyslaw Gajda, 2010, Acta radiologica.

Differential Diagnosis of Breast Lesions 5 mm or Less: Is There a Role for Magnetic Resonance Imaging?

W. Kaiser, M. Dietzel, P. Baltzer, 2010, Journal of computer assisted tomography.

Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques

J. R. Reichenbach, W. A. Kaiser, W. Kaiser, 2009, European Radiology.

Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy

T. Kroll, I. Runnebaum, K. Pachmann, 2010, Journal of Cancer Research and Clinical Oncology.

Pegylated liposomal doxorubicin (CAELYX®) in patients with advanced ovarian cancer: results of a German multicenter observational study

H. Tesch, J. Sehouli, O. Camara, 2009, Cancer Chemotherapy and Pharmacology.

Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2‐negative, Hormone Receptor‐positive Early Breast Cancer

P. Fasching, T. Fehm, A. Schneeweiss, 2017, Clinical breast cancer.

Fifth International Congress on MR-Mammography 24–26 September 2009, Jena, Germany

W. Kaiser, M. Dietzel, P. Baltzer, 2009, European Radiology.

Laparoscopic myomectomy in peri- and post-menopausal women is safe, efficacious and associated with long-term patient satisfaction.

O. Camara, H. Diebolder, I. Runnebaum, 2012, European journal of obstetrics, gynecology, and reproductive biology.

Diffusion tensor magnetic resonance imaging of the breast: a pilot study

Matthias Dietzel, Mieczyslaw Gajda, Oumar Camara, 2010, European Radiology.

The Adjacent Vessel Sign on Breast MRI: New Data and a Subgroup Analysis for 1,084 Histologically Verified Cases

W. Kaiser, M. Dietzel, P. Baltzer, 2010, Korean journal of radiology.

Sequential chemotherapy with carboplatin followed by weekly paclitaxel in advanced ovarian cancer: results of a multicenter phase II study of the northeastern German society of gynecological oncology.

H. Sommer, W. Lichtenegger, J. Sehouli, 2010, Gynecologic oncology.

Phase II study of weekly docetaxel in patients with recurrent or metastatic endometrial cancer: AGO Uterus-4.

M. Beckmann, L. Kiesel, G. Emons, 2007, Gynecologic oncology.

Abstract P1-11-03: Pathological Complete Response after Neoadjuvant Chemotherapy + Trastuzumab Treatment Predicts Survival and Detects a Patient Subgroup at High Need for Improvement of Anti-HER2 Therapy. Three Year Median Follow-Up Data of the TECHNO Trial

P. Fasching, T. Kühn, R. Kreienberg, 2010 .

Abstract P3-12-09: The prevalence and quantity of circulating tumor cells (CTCs) after adjuvant chemotherapy with and without anthracyclines in patients with HER2-negative early breast cancer (EBC)

M. Beckmann, P. Fasching, T. Fehm, 2013 .

Seeding of epithelial cells into circulation during surgery for breast cancer: the fate of malignant and benign mobilized cells

K. Pachmann, O. Camara, A. Kavallaris, 2006, World journal of surgical oncology.

[Clinical value of computer-assisted analysis in MR mammography. A comparison between two systems and three observers with different levels of experience].

W. Kaiser, J. Böttcher, O. Camara, 2008, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy.

J. Blohmer, W. Lichtenegger, J. Sehouli, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Ultrasound-guided breast biopsy using a 10-gauge self-contained vacuum-assisted device

W. Kaiser, S. Pfleiderer, S. Wurdinger, 2007, European Radiology.

Application of computer-aided diagnosis (CAD) in MR-mammography (MRM): do we really need whole lesion time curve distribution analysis?

Mieczyslaw Gajda, Oumar Camara, Werner A Kaiser, 2009, Academic radiology.

H. Sommer, J. Sehouli, J. Einenkel, 2012, Anticancer research.

Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma

O. Camara, A. Schneider, H. Oelschläger, 2007, Journal of Cancer Research and Clinical Oncology.

PREPARE trial. A randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF with a standard dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer: A preplanned interim analysis of eff

P. Fasching, S. Loibl, I. Bauerfeind, 2008 .

Treatment of endometriosis of uterosacral ligament and rectum through the vagina: description of a modified technique.

O. Camara, A. Kavallaris, M. Gajda, 2009, Human reproduction.

Weekly paclitaxel and carboplatin (PC-W) for patients with primary advanced ovarian cancer: results of a multicenter phase-II study of the NOGGO

W. Lichtenegger, J. Sehouli, G. Gebauer, 2007, Cancer Chemotherapy and Pharmacology.

Laparoscopic lymphocele fenestration in gynaecological cancer patients after retroperitoneal lymph node dissection as a first‐line treatment option

O. Camara, H. Diebolder, I. Runnebaum, 2013, BJOG: an International Journal of Obstetrics and Gynaecology.

Computer-aided interpretation of dynamic magnetic resonance imaging reflects histopathology of invasive breast cancer

Werner A. Kaiser, Matthias Dietzel, Tibor Vag, 2010, European Radiology.

Kinetic analysis of lesions without mass effect on breast MRI using manual and computer-assisted methods

Werner A. Kaiser, Matthias Dietzel, Tibor Vag, 2011, European Radiology.

Ultrasound-Guided, Percutaneous Cryotherapy of Small (≤15 mm) Breast Cancers

W. Kaiser, S. Pfleiderer, C. Marx, 2005, Investigative radiology.

Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative study

Joachim Böttcher, Werner A. Kaiser, Mieczyslaw Gajda, 2008, European Radiology.

Impact of age on morbidity and outcome of concurrent radiochemotherapy in high-risk FIGO stage I to IVA carcinoma of the uterine cervix following laparoscopic surgery

T. Wendt, O. Camara, A. Altendorf-Hofmann, 2010, Journal of Cancer Research and Clinical Oncology.

Characteristics of ductal carcinoma in situ in magnetic resonance imaging.

W. Kaiser, M. Facius, J. Böttcher, 2007, Clinical imaging.

Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy.

W. Kaiser, S. Pfleiderer, M. Dietzel, 2011, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

Partial Mastectomy Reconstruction with Local and Distant Tissue Flaps

J. Blohmer, S. Kümmel, O. Camara, 2007, Breast Care.

Venous coupler for free-flap anastomosis.

O. Camara, M. Gajda, I. Runnebaum, 2009, Anticancer research.

The contralateral synchronous breast carcinoma: a comparison of histology, localization, and magnetic resonance imaging characteristics with the primary index cancer

W. Kaiser, J. Böttcher, M. Dietzel, 2010, Breast Cancer Research and Treatment.

Clinical MR-mammography: are computer-assisted methods superior to visual or manual measurements for curve type analysis? A systematic approach.

Matthias Dietzel, Tibor Vag, Pascal Andreas Thomas Baltzer, 2009, Academic radiology.

Kinetic characteristics of ductal carcinoma in situ (DCIS) in dynamic breast MRI using computer-assisted analysis

W. Kaiser, M. Benndorf, M. Dietzel, 2010, Acta radiologica.

Sensitivity and Specificity of Unilateral Edema on T2w‐TSE Sequences in MR‐Mammography Considering 974 Histologically Verified Lesions

W. Kaiser, M. Dietzel, O. Camara, 2010, The breast journal.

Standardized quantification of circulating peripheral tumor cells from lung and breast cancer

Katharina Pachmann, Oumar Camara, J. Clement, 2005, Clinical chemistry and laboratory medicine.

Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment

I. Runnebaum, K. Pachmann, O. Camara, 2009, Journal of Cancer Research and Clinical Oncology.

New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments

M. Montès, G. Pagès, P. Auberger, 2019, Theranostics.

The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer.

M. Untch, K. Pachmann, O. Camara, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer

T. Bauknecht, I. Runnebaum, W. Lichtenegger, 2010, Cancer Chemotherapy and Pharmacology.

Laparoscopic-assisted vaginal hysterectomy with and without laparoscopic transsection of the uterine artery: an analysis of 1,255 cases

O. Camara, A. Kavallaris, D. Beyer, 2011, Archives of Gynecology and Obstetrics.

Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.

P. Fasching, T. Kühn, R. Kreienberg, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reduction mammaplasty for symptomatic macromastia: which factors influence the post-operative outcome?

O. Camara, S. Baum, J. Radosa, 2013, Archives of Gynecology and Obstetrics.

Application of MR mammography beyond local staging: is there a potential to accurately assess axillary lymph nodes? evaluation of an extended protocol in an initial prospective study.

W. Kaiser, M. Dietzel, P. Baltzer, 2011, AJR. American journal of roentgenology.

Long-term risk of fibroid recurrence after laparoscopic myomectomy.

O. Camara, I. Runnebaum, A. Mothes, 2014, European journal of obstetrics, gynecology, and reproductive biology.

Biweekly pegylated liposomal doxorubicin in patients with relapsed ovarian cancer: results of a multicenter phase-II trial.

W. Lichtenegger, J. Sehouli, O. Camara, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Surgical management of multiple bilateral fibroadenoma of the breast: the Ribeiro technique modified by Rezai.

P. Baltzer, O. Camara, M. Gajda, 2009, Anticancer research.

Subareolar blue dye only injection sentinel lymph node biopsy could reduce the numbers of standard axillary lymph node dissection in environments without access to nuclear medicine

O. Camara, A. Kavallaris, I. Runnebaum, 2008, Journal of Cancer Research and Clinical Oncology.

A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO)

M. Lux, I. Runnebaum, T. Trarbach, 2016, Journal of Cancer Research and Clinical Oncology.

Coagulation versus excision of primary superficial endometriosis: a 2-year follow-up.

O. Camara, H. Diebolder, I. Runnebaum, 2010, European journal of obstetrics, gynecology, and reproductive biology.

Phase II study of fulvestrant 250 mg/month in patients with recurrent or metastatic endometrial cancer: a study of the Arbeitsgemeinschaft Gynäkologische Onkologie.

H. Kölbl, T. Reimer, G. Emons, 2013, Gynecologic oncology.

Nonplatinum topotecan combinations versus topotecan alone for recurrent ovarian cancer: results of a phase III study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group.

M. Stauch, H. Sommer, W. Lichtenegger, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative Multimodal Strategies for Risk Assessment of Adnexal Masses: Analysis of 1362 Cases in a Gynecologic Cancer Center

O. Camara, M. Gajda, H. Diebolder, 2011, International Journal of Gynecologic Cancer.

Loss of BRCA1 Protein Expression as Indicator of the BRCAness Phenotype Is Associated With Favorable Overall Survival After Complete Resection of Sporadic Ovarian Cancer

O. Camara, M. Dürst, H. Diebolder, 2011, International Journal of Gynecologic Cancer.

Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions

Matthias Benndorf, Werner A. Kaiser, Matthias Dietzel, 2010, European Radiology.

Two-year follow-up of stereotactically guided 9-G breast biopsy: a multicenter evaluation of a self-contained vacuum-assisted device.

R. Schulz-Wendtland, W. Kaiser, S. Pfleiderer, 2009, Clinical imaging.

The Necrosis Sign in Magnetic Resonance‐Mammography: Diagnostic Accuracy in 1,084 Histologically Verified Breast Lesions

W. Kaiser, M. Dietzel, P. Baltzer, 2010, The breast journal.

Prognostic Value of "Prepectoral Edema" in MR-mammography.

W. Kaiser, S. Schoenberg, M. Dietzel, 2017, Anticancer research.

Diagnosis of ductal carcinoma in situ using contrast-enhanced magnetic resonance mammography compared with conventional mammography.

W. Kaiser, S. Pfleiderer, P. Baltzer, 2008, Clinical imaging.

Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study.

D. Boehmer, K. Münstedt, J. Sehouli, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

The hook sign for differential diagnosis of malignant from benign lesions in magnetic resonance mammography: Experience in a study of 1084 histologically verified cases

W. Kaiser, M. Dietzel, P. Baltzer, 2010, Acta radiologica.

Small-Bowel Obstruction Caused by Duodenal Compression of a Paraaortic Lymphocele

O. Camara, H. Diebolder, I. Runnebaum, 2011, Oncology Research and Treatment.

Magnetic Resonance Mammography of Invasive Lobular Versus Ductal Carcinoma: Systematic Comparison of 811 Patients Reveals High Diagnostic Accuracy Irrespective of Typing

W. Kaiser, M. Dietzel, P. Baltzer, 2010, Journal of computer assisted tomography.

Breast pathology after cryotherapy. Histological regression of breast cancer after cryotherapy.

W. Kaiser, I. Petersen, M. Mireskandari, 2014, Polish journal of pathology : official journal of the Polish Society of Pathologists.

Controversies in the management of ovarian cancer--pros and cons for lymph node dissection in ovarian cancer.

J. Sehouli, O. Camara, 2009, Anticancer research.

Correlation of Ductoscopic and Histopathological Findings and Their Relevance as Predictors for Malignancy: A German Multicenter Study

K. Hegenscheid, T. Kohlmann, R. Ohlinger, 2020, AntiCancer Research.

Heterogeneity of circulating epithelial tumour cells from individual patients with respect to expression profiles and clonal growth (sphere formation) in breast cancer

K. Pachmann, O. Camara, U. Pachmann, 2013, Ecancermedicalscience.

Sonographic Discrimination Between Benign and Malignant Adnexal Masses in Premenopause

U. Schneider, C. Kaehler, O. Camara, 2013, Ultraschall in der Medizin.

Efficacy control of therapy using circulating epithelial tumor cells (CETC) as “Liquid Biopsy”: trastuzumab in HER2/neu-positive breast carcinoma

T. Kroll, I. Runnebaum, J. Wotschadlo, 2011, Journal of Cancer Research and Clinical Oncology.

Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2/neu-positive tumors.

T. Kroll, M. Untch, I. Runnebaum, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Computer Assisted Analysis of MR-Mammography Reveals Association between Contrast Enhancement and Occurrence of Distant Metastasis

W. Kaiser, M. Dietzel, R. Zoubi, 2012, Technology in cancer research & treatment.

Circulating tumor cells: Tools for monitoring and targets for therapy.

I. Runnebaum, K. Pachmann, O. Camara, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of contrast agent on the results of in vivo 1H MRS of breast tumors – is it clinically significant?

W. Kaiser, J. Reichenbach, M. Dietzel, 2012, NMR in biomedicine.

Sentinel lymph node biopsy in vulvar cancer: a pilot study.

O. Camara, M. Gajda, W. Michels, 2009, European Journal of Gynaecological Oncology.

High depletion of breast cancer cells from the peripheral blood with the method of non-specific separation

K. Pachmann, O. Camara, M. Röder, 2020, Ecancermedicalscience.

Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.

T. Kroll, I. Runnebaum, K. Pachmann, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Klinische Wertigkeit computergestützter Analysen in der MR-Mammografie. Ein Vergleich zwischen zwei Systemen und drei Untersuchern mit unterschiedlicher Erfahrung

P. Baltzer, O. Camara, M. Gajda, 2008, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

Ductoscopic Detection of Intraductal Lesions in Cases of Pathologic Nipple Discharge in Comparison with Standard Diagnostics: The German Multicenter Study

K. Hegenscheid, T. Kohlmann, R. Ohlinger, 2014, Oncology Research and Treatment.

Laparoscopic myomectomy in peri- and post-menopausal women is safe, efficacious and associated with long-term patient satisfaction.

O. Camara, H. Diebolder, I. Runnebaum, 2012, European journal of obstetrics, gynecology, and reproductive biology.

Is "prepectoral edema" a morphologic sign for malignant breast tumors?

W. Kaiser, M. Dietzel, P. Baltzer, 2015, Academic radiology.

Topotecan and carboplatin in patients with platinum-sensitive recurrent ovarian cancer. Results of a multicenter NOGGO: phase I/II study

H. Sommer, W. Lichtenegger, J. Sehouli, 2008, Cancer Chemotherapy and Pharmacology.

Abstract P3-12-09: The prevalence and quantity of circulating tumor cells (CTCs) after adjuvant chemotherapy with and without anthracyclines in patients with HER2-negative early breast cancer (EBC)

M. Beckmann, P. Fasching, T. Fehm, 2013 .